|
EP2734621B1
(en)
|
2011-07-22 |
2019-09-04 |
President and Fellows of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
|
AU2012305931B2
(en)
|
2011-09-08 |
2017-09-07 |
Yeda Research And Development Co. Ltd |
Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
|
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
|
US9340800B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
Extended DNA-sensing GRNAS
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
|
SG11201609211VA
(en)
|
2014-03-05 |
2016-12-29 |
Nat Univ Corp Univ Kobe |
Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same
|
|
US11390921B2
(en)
|
2014-04-01 |
2022-07-19 |
Adaptive Biotechnologies Corporation |
Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)
|
|
ES2995052T3
(en)
|
2014-04-23 |
2025-02-05 |
Juno Therapeutics Inc |
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
|
|
CA2956224A1
(en)
|
2014-07-30 |
2016-02-11 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
|
AU2015339743C1
(en)
|
2014-10-31 |
2021-04-22 |
The Trustees Of The University Of Pennsylvania |
Altering gene expression in modified T cells and uses thereof
|
|
US10900034B2
(en)
|
2014-12-03 |
2021-01-26 |
Agilent Technologies, Inc. |
Guide RNA with chemical modifications
|
|
CN113713091A
(zh)
|
2015-02-06 |
2021-11-30 |
新加坡国立大学 |
工程免疫细胞及其用途和生产方法
|
|
CN115537396A
(zh)
*
|
2015-03-27 |
2022-12-30 |
哈佛学院校长同事会 |
经过修饰的t细胞及其制备和使用方法
|
|
KR102888521B1
(ko)
|
2015-04-06 |
2025-11-19 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
Crispr/cas-매개 유전자 조절을 위한 화학적으로 변형된 가이드 rna
|
|
CN107921148A
(zh)
|
2015-05-08 |
2018-04-17 |
哈佛学院校长同事会 |
通用供体干细胞和相关方法
|
|
AU2016291825B2
(en)
|
2015-07-16 |
2022-08-11 |
Yeda Research And Development Co. Ltd. |
Genetically modified anti-third party central memory T cells and use of same in immunotherapy
|
|
IL295616A
(en)
|
2015-07-31 |
2022-10-01 |
Us Health |
Adapted cells and treatment methods
|
|
DK3359184T3
(da)
|
2015-10-05 |
2020-06-15 |
Prec Biosciences Inc |
Genetisk modificerede celler, der omfatter et modificeret gen fra konstant alfaregion i human t-cellereceptor
|
|
DK3359660T3
(en)
|
2015-10-05 |
2020-02-17 |
Prec Biosciences Inc |
Engineered meganucleases with recognition sequences found in the human t cell receptor alpha constant region gene
|
|
EP4434589A3
(en)
|
2015-10-23 |
2025-05-14 |
President and Fellows of Harvard College |
Evolved cas9 proteins for gene editing
|
|
WO2017090761A1
(ja)
|
2015-11-27 |
2017-06-01 |
国立大学法人神戸大学 |
標的化したｄｎａ配列の核酸塩基を特異的に変換する、単子葉植物のゲノム配列の変換方法、及びそれに用いる分子複合体
|
|
AU2016363025B2
(en)
|
2015-12-03 |
2021-04-08 |
Juno Therapeutics, Inc. |
Modified chimeric receptors and related compositions and methods
|
|
IL259576B
(en)
|
2015-12-04 |
2022-09-01 |
Novartis Ag |
grna molecule containing tracr and crrna, pharmaceutical composition containing it and method for preparing cells for immunotherapy
|
|
US20170199961A1
(en)
|
2015-12-16 |
2017-07-13 |
Gritstone Oncology, Inc. |
Neoantigen Identification, Manufacture, and Use
|
|
WO2017192536A1
(en)
|
2016-05-02 |
2017-11-09 |
University Of Kansas |
Eliminating mhc restriction from the t cell receptor as a strategy for immunotherapy
|
|
US10767175B2
(en)
|
2016-06-08 |
2020-09-08 |
Agilent Technologies, Inc. |
High specificity genome editing using chemically modified guide RNAs
|
|
CN109963598A
(zh)
*
|
2016-07-05 |
2019-07-02 |
约翰霍普金斯大学 |
用于治疗癌症的基于crispr/cas9的组合物和方法
|
|
MX2019000251A
(es)
*
|
2016-07-05 |
2019-10-09 |
Univ Johns Hopkins |
Composiciones y metodos que comprenden mejoras de los arn guias de crispr usando el promotor h1.
|
|
CN106191062B
(zh)
*
|
2016-07-18 |
2019-06-14 |
广东华南疫苗股份有限公司 |
一种tcr-/pd-1-双阴性t细胞及其构建方法
|
|
WO2018027036A1
(en)
|
2016-08-03 |
2018-02-08 |
Dipersio John F |
Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors
|
|
JP7231935B2
(ja)
|
2016-08-03 |
2023-03-08 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
アデノシン核酸塩基編集因子およびそれらの使用
|
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
|
ES2998057T3
(en)
|
2016-08-12 |
2025-02-18 |
Toolgen Inc |
Manipulated immunoregulatory element and immunity altered thereby
|
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
CN106399375A
(zh)
*
|
2016-08-31 |
2017-02-15 |
南京凯地生物科技有限公司 |
利用CRISPR/Cas9敲除人PD‑1基因构建靶向CD19CAR‑T细胞的方法
|
|
CN106480097A
(zh)
*
|
2016-10-13 |
2017-03-08 |
南京凯地生物科技有限公司 |
利用CRISPR/Cas9技术敲除人PD‑1基因构建可靶向MSLN新型CAR‑T细胞的方法及其应用
|
|
MA46354A
(fr)
*
|
2016-10-03 |
2019-08-07 |
Juno Therapeutics Inc |
Molécules se liant spécifiquement au vph
|
|
AU2017342543B2
(en)
|
2016-10-14 |
2024-06-27 |
President And Fellows Of Harvard College |
AAV delivery of nucleobase editors
|
|
EP4338799A3
(en)
|
2016-10-18 |
2024-06-05 |
Regents of the University of Minnesota |
Tumor infiltrating lymphocytes and methods of therapy
|
|
GB2607227B
(en)
*
|
2016-10-27 |
2023-05-10 |
Intima Bioscience Inc |
Viral methods of T cell therapy
|
|
WO2018083318A1
(en)
|
2016-11-07 |
2018-05-11 |
Genovie Ab |
A two-part device for t-cell receptor synthesis and stable genomic integration to tcr-presenting cells
|
|
EP4464782A3
(en)
*
|
2016-11-07 |
2025-05-07 |
Genovie AB |
An engineered multi-component system for identification and characterisation of t-cell receptors, t-cell antigens and their functional interaction
|
|
KR102625785B1
(ko)
|
2016-11-07 |
2024-01-16 |
제노비에 에이비 |
T-세포 수용체 및 t-세포 항원의 식별 및 특징규명을 위한 조작된 다성분 시스템
|
|
GB201622044D0
(en)
*
|
2016-12-22 |
2017-02-08 |
Ucl Business Plc |
T cell-targeted T cells
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
US12459975B2
(en)
|
2017-01-10 |
2025-11-04 |
The General Hospital Corporation |
Modified T cells and methods of their use
|
|
WO2018132508A1
(en)
*
|
2017-01-10 |
2018-07-19 |
The General Hospital Corporation |
Methods and compositions relating to ex vivo culture and modulation of t cells
|
|
EP3571295B1
(en)
*
|
2017-01-18 |
2026-01-07 |
Yeda Research and Development Co. Ltd |
Genetically modified veto cells and use of same in immunotherapy
|
|
CN110662556A
(zh)
|
2017-03-09 |
2020-01-07 |
哈佛大学的校长及成员们 |
癌症疫苗
|
|
US11898179B2
(en)
|
2017-03-09 |
2024-02-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
|
JP2020510439A
(ja)
|
2017-03-10 |
2020-04-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
シトシンからグアニンへの塩基編集因子
|
|
JP7359751B2
(ja)
*
|
2017-03-14 |
2023-10-11 |
ジュノー セラピューティクス インコーポレイテッド |
極低温保管のための方法
|
|
CA3054621A1
(en)
*
|
2017-03-22 |
2018-09-27 |
Novartis Ag |
Compositions and methods for immunooncology
|
|
WO2018176009A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
|
US10934336B2
(en)
|
2017-04-13 |
2021-03-02 |
The Trustees Of The University Of Pennsylvania |
Use of gene editing to generate universal TCR re-directed T cells for adoptive immunotherapy
|
|
CN110785489A
(zh)
*
|
2017-05-04 |
2020-02-11 |
宾夕法尼亚大学董事会 |
使用CRISPR/Cpf1在T细胞中进行基因编辑的组合物和方法
|
|
WO2018208837A1
(en)
*
|
2017-05-08 |
2018-11-15 |
Precision Biosciences, Inc. |
Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
|
|
AU2018264636B2
(en)
|
2017-05-08 |
2022-03-17 |
Toolgen Incorporated |
Artificially manipulated immune cell
|
|
US11166985B2
(en)
|
2017-05-12 |
2021-11-09 |
Crispr Therapeutics Ag |
Materials and methods for engineering cells and uses thereof in immuno-oncology
|
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
|
IL270415B2
(en)
|
2017-05-12 |
2024-08-01 |
Crispr Therapeutics Ag |
Materials and methods for cell engineering and their uses in immuno-oncology
|
|
CN110944652A
(zh)
*
|
2017-06-12 |
2020-03-31 |
爱莫里大学 |
T细胞抗原靶向的嵌合抗原受体(car)以及在细胞疗法中的用途
|
|
MX2019015188A
(es)
|
2017-06-15 |
2020-08-03 |
Univ California |
Inserciones de adn no virales orientadas.
|
|
WO2018236909A1
(en)
*
|
2017-06-20 |
2018-12-27 |
La Jolla Institute For Allergy And Immunology |
Engineered t-cell receptors and methods of their use in modulating inflammatory responses and treating atherosclerosis
|
|
CN109963944A
(zh)
*
|
2017-06-20 |
2019-07-02 |
江苏恒瑞医药股份有限公司 |
体外敲除T细胞中靶基因的方法以及该方法中使用的crRNA
|
|
CA3068465A1
(en)
|
2017-06-30 |
2019-01-03 |
Precision Biosciences, Inc. |
Genetically-modified t cells comprising a modified intron in the t cell receptor alpha gene
|
|
EP3645021A4
(en)
|
2017-06-30 |
2021-04-21 |
Intima Bioscience, Inc. |
ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY
|
|
US11732274B2
(en)
|
2017-07-28 |
2023-08-22 |
President And Fellows Of Harvard College |
Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
|
|
US11648269B2
(en)
|
2017-08-10 |
2023-05-16 |
National University Of Singapore |
T cell receptor-deficient chimeric antigen receptor T-cells and methods of use thereof
|
|
EP3441461A1
(en)
*
|
2017-08-11 |
2019-02-13 |
Baylor College of Medicine |
Cd1d-restricted nkt cells as a platform for off-the-shelf cancer immunotherapy
|
|
WO2019139645A2
(en)
|
2017-08-30 |
2019-07-18 |
President And Fellows Of Harvard College |
High efficiency base editors comprising gam
|
|
CN109456943A
(zh)
*
|
2017-09-06 |
2019-03-12 |
亘喜生物科技（上海）有限公司 |
通用型嵌合抗原受体t细胞制备技术
|
|
US20200261502A1
(en)
*
|
2017-09-08 |
2020-08-20 |
Carsgen Therapeutics Co., Ltd. |
Genetically engineered t cell and application thereof
|
|
CN111194350A
(zh)
*
|
2017-09-18 |
2020-05-22 |
博雅辑因（北京）生物科技有限公司 |
一种基因编辑t细胞及其用途
|
|
CA3076337A1
(en)
|
2017-09-19 |
2019-03-28 |
Massachusetts Institute Of Technology |
Compositions for chimeric antigen receptor t cell therapy and uses thereof
|
|
CN109517820B
(zh)
|
2017-09-20 |
2021-09-24 |
北京宇繁生物科技有限公司 |
一种靶向HPK1的gRNA以及HPK1基因编辑方法
|
|
CN107630006B
(zh)
*
|
2017-09-30 |
2020-09-11 |
山东兴瑞生物科技有限公司 |
一种制备tcr与hla双基因敲除的t细胞的方法
|
|
CN111954679A
(zh)
|
2017-10-03 |
2020-11-17 |
朱诺治疗学股份有限公司 |
Hpv特异性结合分子
|
|
WO2019073965A1
(ja)
|
2017-10-10 |
2019-04-18 |
国立大学法人広島大学 |
エフェクターＴ細胞（Ｔｅｆｆ）抗原受容体を用いた抗原特異的制御性Ｔ細胞（Ｔｒｅｇ）の作出技術
|
|
ES3029080T3
(en)
|
2017-10-10 |
2025-06-23 |
Seattle Project Corp |
Neoantigen identification using hotspots
|
|
CN111479830A
(zh)
*
|
2017-10-10 |
2020-07-31 |
国立大学法人广岛大学 |
使用铂talen的t细胞受体的完全取代技术
|
|
KR20200121782A
(ko)
|
2017-10-16 |
2020-10-26 |
더 브로드 인스티튜트, 인코퍼레이티드 |
아데노신 염기 편집제의 용도
|
|
CN107759699A
(zh)
*
|
2017-10-18 |
2018-03-06 |
银丰生物工程集团有限公司 |
靶向cd30抗原的转基因t细胞及其制备方法与应用
|
|
CN107827989A
(zh)
*
|
2017-10-18 |
2018-03-23 |
银丰生物工程集团有限公司 |
靶向骨髓瘤bcma抗原的转基因t细胞及其制备方法与应用
|
|
CN107759700A
(zh)
*
|
2017-10-18 |
2018-03-06 |
银丰生物工程集团有限公司 |
靶向cd19抗原的转基因t细胞及其制备方法与应用
|
|
CN107723275B
(zh)
*
|
2017-10-20 |
2020-09-04 |
重庆精准生物技术有限公司 |
通用型car-t细胞及其制备方法和应用
|
|
JP7101419B2
(ja)
|
2017-10-27 |
2022-07-15 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
内因性ｔ細胞受容体の標的置換
|
|
CN117904055A
(zh)
|
2017-10-30 |
2024-04-19 |
派克特制药公司 |
原代细胞基因编辑
|
|
CN107916269B
(zh)
*
|
2017-11-17 |
2020-12-11 |
山东兴瑞生物科技有限公司 |
靶向cd19的tcr基因、制备方法、具有该基因的质粒、试剂盒及应用
|
|
US11885815B2
(en)
|
2017-11-22 |
2024-01-30 |
Gritstone Bio, Inc. |
Reducing junction epitope presentation for neoantigens
|
|
WO2019106163A1
(en)
*
|
2017-12-01 |
2019-06-06 |
Cellectis |
Reprogramming of genetically engineered primary immune cells
|
|
CN111712569A
(zh)
*
|
2017-12-11 |
2020-09-25 |
爱迪塔斯医药公司 |
用于基因编辑的Cpf1-相关方法和组合物
|
|
WO2019118508A1
(en)
*
|
2017-12-12 |
2019-06-20 |
The Trustees Of The University Of Pennsylvania |
Genetically modified immune cells targeting ny-eso-1 and methods of use thereof
|
|
CN111479917A
(zh)
*
|
2017-12-13 |
2020-07-31 |
詹森生物科技公司 |
经基因修饰以消除T细胞受体和β2-微球蛋白表达的永生化CAR-T细胞
|
|
US12406749B2
(en)
|
2017-12-15 |
2025-09-02 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
US12365733B2
(en)
|
2017-12-29 |
2025-07-22 |
Cellectis |
Method for improving production of car T cells
|
|
CN108559760A
(zh)
*
|
2018-01-09 |
2018-09-21 |
陕西师范大学 |
基于CRISPR靶向基因组修饰技术建立荧光素酶knock-in细胞系的方法
|
|
US12247060B2
(en)
|
2018-01-09 |
2025-03-11 |
Marengo Therapeutics, Inc. |
Calreticulin binding constructs and engineered T cells for the treatment of diseases
|
|
US11679129B2
(en)
|
2018-01-12 |
2023-06-20 |
Curocell, Inc. |
Enhanced immune cells using dual shRNA and composition including the same
|
|
EP3765054A4
(en)
*
|
2018-01-19 |
2022-01-12 |
The Trustees Of The University Of Pennsylvania |
COMPOSITIONS AND METHODS FOR TARGETING GAMMA DELTA T LYMPHOCYTES USING CHIMERIC ANTIGEN RECEPTORS
|
|
CN108103027B
(zh)
*
|
2018-02-02 |
2021-12-24 |
中国医学科学院血液病医院（血液学研究所） |
高效率血细胞重编程同时实现基因编辑的方法
|
|
EP3749687A4
(en)
*
|
2018-02-11 |
2021-12-29 |
Memorial Sloan Kettering Cancer Center |
Non-hla restricted t cell receptors and uses thereof
|
|
TW202000693A
(zh)
|
2018-02-27 |
2020-01-01 |
美商葛利史東腫瘤科技公司 |
利用泛對偶基因（pan-allele）模型之新抗原鑑別
|
|
CN112119157B
(zh)
|
2018-03-06 |
2025-01-14 |
宾夕法尼亚大学董事会 |
前列腺特异性膜抗原car及其使用方法
|
|
CN118325839A
(zh)
|
2018-03-27 |
2024-07-12 |
宾夕法尼亚大学董事会 |
具有增强功能的修饰的免疫细胞及其筛选方法
|
|
EP3775214A2
(en)
|
2018-03-30 |
2021-02-17 |
University of Geneva |
Micro rna expression constructs and uses thereof
|
|
SG11202009761YA
(en)
|
2018-04-02 |
2020-10-29 |
Pact Pharma Inc |
Peptide-mhc compacts
|
|
EP3775237A1
(en)
|
2018-04-05 |
2021-02-17 |
Juno Therapeutics, Inc. |
T cells expressing a recombinant receptor, related polynucleotides and methods
|
|
TWI840351B
(zh)
*
|
2018-04-05 |
2024-05-01 |
美商奇諾治療有限公司 |
T細胞受體及表現其之工程化細胞
|
|
KR20210029707A
(ko)
|
2018-04-05 |
2021-03-16 |
주노 쎄러퓨티크스 인코퍼레이티드 |
재조합 수용체를 발현하는 세포의 생산 방법 및 관련 조성물
|
|
US11786554B2
(en)
|
2018-04-12 |
2023-10-17 |
Precision Biosciences, Inc. |
Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region gene
|
|
CN108490174B
(zh)
*
|
2018-04-18 |
2022-06-24 |
上海尚珞生物医药科技有限公司 |
检测car-t细胞的方法及其应用
|
|
CN112368013B
(zh)
*
|
2018-04-26 |
2025-05-16 |
贝勒医学院 |
用于选择性靶向活化的致病性t细胞和nk细胞的自体/同种异体免疫防御受体
|
|
WO2019215500A1
(en)
|
2018-05-11 |
2019-11-14 |
Crispr Therapeutics Ag |
Methods and compositions for treating cancer
|
|
CN112654710A
(zh)
|
2018-05-16 |
2021-04-13 |
辛瑟高公司 |
用于指导rna设计和使用的方法和系统
|
|
US12157760B2
(en)
|
2018-05-23 |
2024-12-03 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
SG11202011383VA
(en)
*
|
2018-05-31 |
2020-12-30 |
Univ Washington |
Chimeric antigen receptor t cells (car-t) for the treatment of cancer
|
|
US20200109364A1
(en)
*
|
2018-05-31 |
2020-04-09 |
Washington University |
Methods for genome-editing and activation of cells
|
|
CN110616188B
(zh)
*
|
2018-06-20 |
2023-05-09 |
上海隆耀生物科技有限公司 |
一种通用型car-t细胞及其制备方法和应用
|
|
CA3105448A1
(en)
|
2018-07-03 |
2020-01-09 |
Elstar Therapeutics, Inc. |
Anti-tcr antibody molecules and uses thereof
|
|
US12522807B2
(en)
|
2018-07-09 |
2026-01-13 |
The Broad Institute, Inc. |
RNA programmable epigenetic RNA modifiers and uses thereof
|
|
CN112805369A
(zh)
*
|
2018-08-08 |
2021-05-14 |
南特生物公司 |
重组cd1限制性t细胞及方法
|
|
CN110904045A
(zh)
*
|
2018-09-17 |
2020-03-24 |
中国科学院动物研究所 |
经修饰的t细胞、其制备方法及用途
|
|
US20220016166A1
(en)
*
|
2018-09-21 |
2022-01-20 |
Cafa Therapeutics Limited |
T-cell expressing chimeric receptor
|
|
WO2020067004A1
(ja)
*
|
2018-09-25 |
2020-04-02 |
公益財団法人微生物化学研究会 |
新規ウイルスベクターおよびその製造方法と使用方法
|
|
MX2021003435A
(es)
|
2018-09-28 |
2021-06-15 |
Massachusetts Inst Technology |
Moleculas inmunomoduladoras localizadas en el colageno y metodos de las mismas.
|
|
CN109295106B
(zh)
*
|
2018-09-30 |
2020-07-24 |
北京鼎成肽源生物技术有限公司 |
一种hafft1细胞
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
AU2019362879B2
(en)
*
|
2018-10-16 |
2026-02-19 |
Intellia Therapeutics, Inc. |
Compositions and methods for immunotherapy
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
US12146157B2
(en)
*
|
2018-11-07 |
2024-11-19 |
Crispr Therapeutics Ag |
Anti-PTK7 immune cell cancer therapy
|
|
CN113227141A
(zh)
*
|
2018-11-07 |
2021-08-06 |
克里斯珀医疗股份公司 |
抗cd33免疫细胞癌症疗法
|
|
CN113015750A
(zh)
*
|
2018-11-07 |
2021-06-22 |
克里斯珀医疗股份公司 |
抗liv1免疫细胞癌症疗法
|
|
CN111788302A
(zh)
*
|
2018-11-21 |
2020-10-16 |
南京北恒生物科技有限公司 |
修饰的t细胞及其用途
|
|
CN120005921A
(zh)
|
2018-12-12 |
2025-05-16 |
凯德药业股份有限公司 |
嵌合抗原和t细胞受体及使用的方法
|
|
CN109722437B
(zh)
*
|
2018-12-29 |
2020-01-07 |
广州百暨基因科技有限公司 |
一种通用型car-t细胞及其制备方法和用途
|
|
CN109652378B
(zh)
*
|
2018-12-29 |
2020-04-24 |
广州百暨基因科技有限公司 |
一种功能增强的通用型car-t细胞及其制备方法和用途
|
|
AU2020208616A1
(en)
*
|
2019-01-16 |
2021-08-12 |
Beam Therapeutics Inc. |
Modified immune cells having enhanced anti-neoplasia activity and immunosuppression resistance
|
|
WO2020150633A1
(en)
|
2019-01-18 |
2020-07-23 |
Orthobio Therapeutics, Inc. |
Gene editing to improve joint function
|
|
WO2020154500A1
(en)
|
2019-01-23 |
2020-07-30 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
SG11202108613RA
(en)
|
2019-02-12 |
2021-09-29 |
Pact Pharma Inc |
Compositions and methods for identification of antigen specific t cells
|
|
GB2597851B
(en)
|
2019-02-21 |
2024-05-29 |
Marengo Therapeutics Inc |
Antibody molecules that bind to NKP30 and uses thereof
|
|
EP3927744A1
(en)
*
|
2019-02-21 |
2021-12-29 |
Marengo Therapeutics, Inc. |
Multifunctional molecules that bind to t cell related cancer cells and uses thereof
|
|
US20220056536A1
(en)
|
2019-02-22 |
2022-02-24 |
Garvan Institute Of Medical Research |
Methods of modulating immune response
|
|
CN109913501B
(zh)
*
|
2019-03-01 |
2022-08-16 |
华东师范大学 |
一种靶向cd152的复制缺陷性重组慢病毒car-t转基因载体及构建方法
|
|
CN111676195A
(zh)
*
|
2019-03-11 |
2020-09-18 |
北京卡替医疗技术有限公司 |
一种治疗t细胞肿瘤的ucar免疫细胞
|
|
AU2020243431B2
(en)
|
2019-03-18 |
2025-12-18 |
Ludwig Institute For Cancer Research Ltd. |
A2/NY-ESO-1 specific T cell receptors and uses thereof
|
|
MX2021011426A
(es)
|
2019-03-19 |
2022-03-11 |
Broad Inst Inc |
Metodos y composiciones para editar secuencias de nucleótidos.
|
|
CA3130701A1
(en)
*
|
2019-03-21 |
2020-09-24 |
Yajin Ni |
Methods for enhancing tcr.alpha..beta.+cell depletion efficiency
|
|
KR20240122580A
(ko)
|
2019-04-03 |
2024-08-12 |
프리시젼 바이오사이언시스 인코포레이티드 |
마이크로RNA-적응 shRNA(shRNAmiR)를 포함하는 유전자-변형 면역 세포
|
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
US20220249558A1
(en)
*
|
2019-04-30 |
2022-08-11 |
Crispr Therapeutics Ag |
Allogeneic cell therapy of b cell malignancies using genetically engineered t cells targeting cd19
|
|
US11642409B2
(en)
|
2019-06-26 |
2023-05-09 |
Massachusetts Insttute of Technology |
Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
|
|
CN112430575B
(zh)
*
|
2019-08-26 |
2024-01-19 |
深圳市菲鹏生物治疗股份有限公司 |
通用型car-t细胞及其制备方法、应用以及抗肿瘤药物
|
|
CN114729325A
(zh)
|
2019-09-06 |
2022-07-08 |
克里斯珀医疗股份公司 |
在培养物中具有改善的持久性的基因工程化t细胞
|
|
WO2021061648A1
(en)
|
2019-09-23 |
2021-04-01 |
Massachusetts Institute Of Technology |
Methods and compositions for stimulation of endogenous t cell responses
|
|
KR20220090512A
(ko)
*
|
2019-09-27 |
2022-06-29 |
빔 테라퓨틱스, 인크. |
액체암의 치료를 위한 조성물 및 방법
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
TW202132560A
(zh)
*
|
2019-11-13 |
2021-09-01 |
瑞士商Ｃｒｉｓｐｒ治療公司 |
製備car-t細胞之方法
|
|
IL292329A
(en)
*
|
2019-11-13 |
2022-06-01 |
Crispr Therapeutics Ag |
Manufacturing process for making t cells expressing chimeric antigen receptors
|
|
CN114729315B
(zh)
*
|
2019-11-20 |
2025-07-22 |
卡瑟里克斯私人有限公司 |
用于提供具有增强功能的免疫细胞的方法
|
|
WO2021108557A1
(en)
*
|
2019-11-27 |
2021-06-03 |
Stitch Bio, Llc |
Methods and compositions for inducing tumor cell death
|
|
CA3163304A1
(en)
*
|
2020-01-02 |
2021-07-08 |
Xiaoyun SHANG |
Modified immune effector cell and preparation method therefor
|
|
EP4084823A4
(en)
|
2020-01-03 |
2024-05-15 |
Marengo Therapeutics, Inc. |
ANTI-TCR ANTIBODY MOLECULES AND THEIR USES
|
|
CN114929867A
(zh)
*
|
2020-01-21 |
2022-08-19 |
苏州克睿基因生物科技有限公司 |
一种经修饰的免疫效应细胞及其用途
|
|
WO2021150078A1
(ko)
*
|
2020-01-23 |
2021-07-29 |
주식회사 강스템바이오텍 |
Off-the-shelf 줄기세포 및 면역세포, 이를 포함하는 약학적 조성물
|
|
US11414700B2
(en)
|
2020-04-21 |
2022-08-16 |
Tempus Labs, Inc. |
TCR/BCR profiling using enrichment with pools of capture probes
|
|
US20210340524A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
|
|
US12433954B2
(en)
|
2020-05-01 |
2025-10-07 |
Massachusetts Institute Of Technology |
Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using amphiphilic ligand conjugates comprising CAR-targeting protein sequence motifs
|
|
WO2021226558A1
(en)
|
2020-05-08 |
2021-11-11 |
The Broad Institute, Inc. |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
|
CN113684258B
(zh)
|
2020-05-18 |
2024-08-20 |
上海赛比曼生物科技有限公司 |
用于检测鼠源tcr转基因拷贝数的试剂盒及方法
|
|
CN116322750A
(zh)
*
|
2020-06-25 |
2023-06-23 |
卫理公会医院 |
抗原特异性t细胞受体和嵌合抗原受体以及用于癌症免疫疗法的免疫信号传导调节中的使用方法
|
|
EP4171616A1
(en)
|
2020-06-26 |
2023-05-03 |
Juno Therapeutics GmbH |
Engineered t cells conditionally expressing a recombinant receptor, related polynucleotides and methods
|
|
WO2022012531A1
(zh)
*
|
2020-07-14 |
2022-01-20 |
苏州克睿基因生物科技有限公司 |
一种经修饰的免疫细胞的制备方法
|
|
JP7623020B2
(ja)
*
|
2020-07-15 |
2025-01-28 |
バイオヘン セラピューティクス リミテッド |
同種異系移植のための操作された免疫細胞
|
|
BR112023000738A2
(pt)
*
|
2020-07-16 |
2023-03-21 |
Orthobio Therapeutics Inc |
Composições farmacêuticas, métodos para o tratamento ou prevenção de uma doença, tratar claudicação canina, tratar claudicação equina, inativar uma il-1a ou il-1ss endógena e reduzir a expressão do gene il-1a ou il-1ss, método de tratamento de um indivíduo com artrite, doença articular e osteoartrite, método mediado por crispr/cas9 para tratamento de doenças articulares, nuclease crisprcas, repetições palindrômicas, sistema vetorial e método de alteração de uma sequência de ácido nucleico
|
|
EP4100028A4
(en)
*
|
2020-08-20 |
2023-07-26 |
A2 Biotherapeutics, Inc. |
Compositions and methods for treating mesothelin positive cancers
|
|
WO2022067089A1
(en)
|
2020-09-25 |
2022-03-31 |
Beam Therapeutics Inc. |
Fratricide resistant modified immune cells and methods of using the same
|
|
JP2023546067A
(ja)
*
|
2020-10-13 |
2023-11-01 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
ｍＲＮＡ治療剤のためのＴ細胞のインビボ標的化
|
|
CN112266899A
(zh)
*
|
2020-10-26 |
2021-01-26 |
北京卡替医疗技术有限公司 |
修饰的免疫细胞及其用途
|
|
EP4247843A1
(en)
*
|
2020-11-23 |
2023-09-27 |
Ludwig-Maximilians-Universität München |
Cd28-targeting chimeric antigen receptor (car) t cells, methods of generation and uses thereof
|
|
WO2022113056A1
(en)
|
2020-11-30 |
2022-06-02 |
Crispr Therapeutics Ag |
Gene-edited natural killer cells
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
TW202237827A
(zh)
|
2020-12-03 |
2022-10-01 |
美商世紀治療股份有限公司 |
經基因工程改造之細胞及其用途
|
|
EP4271798A1
(en)
|
2020-12-30 |
2023-11-08 |
CRISPR Therapeutics AG |
Compositions and methods for differentiating stem cells into nk cells
|
|
CN112899227B
(zh)
*
|
2021-01-14 |
2022-09-13 |
中国科学院微生物研究所 |
一种调控辅助性t细胞功能的方法
|
|
US20240108654A1
(en)
|
2021-03-03 |
2024-04-04 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and a dgk inhibitor
|
|
KR20230151518A
(ko)
*
|
2021-03-04 |
2023-11-01 |
알로젠 테라퓨틱스 인코포레이티드 |
치료 세포를 동종이계 거부반응 및 활성화 유도된 세포 사멸로부터 보호하기 위한 FasL 발현 및 FasR 유전자 녹아웃
|
|
JP2024512368A
(ja)
*
|
2021-03-08 |
2024-03-19 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
Ｔ細胞機能障害を評価および治療するための組成物および方法
|
|
WO2023039586A1
(en)
|
2021-09-10 |
2023-03-16 |
Agilent Technologies, Inc. |
Guide rnas with chemical modification for prime editing
|
|
US20240390493A1
(en)
*
|
2021-09-29 |
2024-11-28 |
The Johns Hopkins University |
Methods and compositions to augment efficacy and reduce toxicity of non-engrafting, cd8-depleted allogenic donor lymphocyte infusions
|
|
EP4413031A1
(en)
|
2021-10-06 |
2024-08-14 |
Miltenyi Biotec B.V. & Co. KG |
Method for targeted gene insertion into immune cells
|
|
KR20240099259A
(ko)
|
2021-10-14 |
2024-06-28 |
아스널 바이오사이언시스, 인크. |
공동 발현된 shrna 및 논리 게이트 시스템을 갖는 면역 세포
|
|
WO2023081715A1
(en)
|
2021-11-03 |
2023-05-11 |
Viracta Therapeutics, Inc. |
Combination of car t-cell therapy with btk inhibitors and methods of use thereof
|
|
WO2023081900A1
(en)
|
2021-11-08 |
2023-05-11 |
Juno Therapeutics, Inc. |
Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods
|
|
CN113980907B
(zh)
*
|
2021-12-24 |
2022-03-15 |
山东兴瑞生物科技有限公司 |
一种抗flt3嵌合抗原受体修饰的t细胞及其在制备治疗aml药物中的应用
|
|
CN114591963B
(zh)
*
|
2022-05-10 |
2022-07-19 |
上海优替济生生物医药有限公司 |
sgRNA及利用其构建GM-CSF(-)细胞的方法
|
|
EP4583876A1
(en)
|
2022-09-08 |
2025-07-16 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and continuous or intermittent dgk inhibitor dosing
|
|
WO2024064633A2
(en)
*
|
2022-09-19 |
2024-03-28 |
Emendobio Inc. |
Biallelic knockout of pdcd1
|
|
EP4615960A1
(en)
|
2022-11-09 |
2025-09-17 |
C3S2 GmbH |
Methods for manufacturing engineered immune cells
|
|
AU2023390911A1
(en)
*
|
2022-12-09 |
2025-03-27 |
Research Institute At Nationwide Children's Hospital |
Chimeric antigen receptor (car) t cells and uses thereof
|
|
EP4630014A1
(en)
*
|
2022-12-09 |
2025-10-15 |
CeMM - Forschungszentrum für Molekulare Medizin GmbH |
Method for optimizing t cells for immuno-therapy
|
|
CN121002052A
(zh)
|
2023-02-03 |
2025-11-21 |
C3S2 有限公司 |
用于非病毒生产工程化免疫细胞的方法
|
|
JP2026505337A
(ja)
*
|
2023-02-10 |
2026-02-13 |
南京北恒生物科技有限公司 |
機能が強化した細胞療法
|
|
JP2026507228A
(ja)
|
2023-03-03 |
2026-02-27 |
アーセナル バイオサイエンシズ インコーポレイテッド |
Ｐｓｍａ及びｃａ９を標的とするシステム
|
|
WO2025082418A1
(zh)
*
|
2023-10-18 |
2025-04-24 |
苏州沙砾生物科技有限公司 |
一种鉴定靶标的方法及其应用
|
|
WO2026025092A1
(en)
|
2024-07-26 |
2026-01-29 |
Juno Therapeutics, Inc. |
Synthetic promoters for t cell expression
|